Cell lines require immortalization, raising cancer-equivalence fears

Normal animal cells divide only 20-30 times before entering senescence (the Hayflick limit). To produce cultivated meat at industrial scale, cell lines must be immortalized — engineered or selected to divide indefinitely. So what? Immortalized cells, by definition, have bypassed the normal cell-cycle checkpoints that prevent uncontrolled proliferation. This is functionally similar to what cancer cells do. So what? Regulators and consumers face an uncomfortable question: are people eating something equivalent to tumor cells? While scientific experts state that ingested immortalized cells are extremely unlikely to survive digestion and form tumors, the association is powerful and difficult to communicate away. So what? In some jurisdictions, spontaneously immortalized cells may be treated as equivalent to cancerous cells under food safety regulations, potentially blocking market access entirely. Genetically engineered immortalization (e.g., TERT overexpression) triggers GMO regulations in the EU and other markets. So what? Companies face a regulatory fork: use spontaneous immortalization (non-GMO but raises cancer-equivalence concerns) or use genetic engineering (more controlled but triggers GMO labeling and potential market bans in the EU, which is the world's largest food market by regulatory influence). Why does this persist? There is no regulatory precedent for evaluating immortalized cell lines as food ingredients. The FDA's GRAS (Generally Recognized as Safe) framework was designed for chemical additives and known food ingredients, not living cells with altered genomes. Building new regulatory frameworks takes years to decades.